JEANETTE MILLER: Open Payments
NPI 1417414665 · TOPEKA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$882 in 49 payments from 16 companies in 2025. Trend: 2023 $583 · 2024 $1,097 · 2025 $882
Food & beverage: $882
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $179 |
| ABBVIE INC. | 4 | $92 |
| Exact Sciences Corporation | 5 | $76 |
| PFIZER INC. | 5 | $74 |
| Otsuka America Pharmaceutical, Inc. | 3 | $70 |
| SHIELD THERAPEUTICS INC | 2 | $68 |
| AstraZeneca Pharmaceuticals LP | 4 | $67 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| Boston Scientific Corporation | 1 | $32 |
| Amgen Inc. | 2 | $32 |
Products named: VRAYLAR, Ozempic, Wegovy, Cologuard Collection Kit, PAXLOVID, REXULTI, ACCRUFER, CAPLYTA.
Industry payments across KS — which companies pay providers there.
